← Back to headlines
Neuronetics Targets 9% Revenue Growth by 2026, Prepares for Compass Therapy Launch
Neuronetics has outlined a target for over 9% revenue growth by 2026, alongside piloting new TMS models and preparing for the launch of its Compass therapy.
17 Mar, 17:13 — 17 Mar, 17:13
Sources
Showing 1 of 1 sources
